DK0624569T3 - MMDA-antagonister - Google Patents
MMDA-antagonisterInfo
- Publication number
- DK0624569T3 DK0624569T3 DK94110261T DK94110261T DK0624569T3 DK 0624569 T3 DK0624569 T3 DK 0624569T3 DK 94110261 T DK94110261 T DK 94110261T DK 94110261 T DK94110261 T DK 94110261T DK 0624569 T3 DK0624569 T3 DK 0624569T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor antagonists
- halo
- formula
- mmda
- mmda receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66267091A | 1991-02-28 | 1991-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0624569T3 true DK0624569T3 (da) | 1998-10-26 |
Family
ID=24658685
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92103066.4T DK0501378T3 (da) | 1991-02-28 | 1992-02-24 | NMDA-antagonister |
| DK94110261T DK0624569T3 (da) | 1991-02-28 | 1992-02-24 | MMDA-antagonister |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92103066.4T DK0501378T3 (da) | 1991-02-28 | 1992-02-24 | NMDA-antagonister |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP0501378B1 (da) |
| JP (1) | JP3168566B2 (da) |
| KR (2) | KR100237264B1 (da) |
| AT (2) | ATE168989T1 (da) |
| AU (2) | AU643365B2 (da) |
| CA (1) | CA2061836C (da) |
| DE (2) | DE69201141T2 (da) |
| DK (2) | DK0501378T3 (da) |
| ES (2) | ES2069921T3 (da) |
| FI (1) | FI920880A (da) |
| GR (1) | GR3015130T3 (da) |
| HU (1) | HU213214B (da) |
| IE (2) | IE65728B1 (da) |
| NO (1) | NO178727C (da) |
| NZ (1) | NZ241718A (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69224069T2 (de) * | 1991-09-09 | 1998-07-02 | Warner-Lambert Co., Ann Arbor, Mich. | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
| US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
| IT1265101B1 (it) * | 1993-07-23 | 1996-10-30 | Erba Carlo Spa | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico |
| US5519055A (en) * | 1993-08-06 | 1996-05-21 | University Of Maryland At Baltimore | Substituted kynurenines and process for their preparation |
| US5786508A (en) * | 1994-07-15 | 1998-07-28 | Pharmacia & Upjohn S.P.A. | Substituted kynurenines and process for their preparation |
| GB9521486D0 (en) * | 1995-10-20 | 1995-12-20 | Pharmacia Spa | Fluoro-substituted benzoylpropionic acid derivatives |
| SE9901237D0 (sv) * | 1999-04-06 | 1999-04-06 | Astra Ab | Novel use |
| EP1964835A1 (en) * | 2007-02-28 | 2008-09-03 | Centre National de la Recherche Scientifique | Derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer |
| KR101308507B1 (ko) * | 2011-07-07 | 2013-09-17 | (주)비알뷰티플레볼루션 | 트립토판을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트 |
| WO2017065899A1 (en) * | 2015-10-16 | 2017-04-20 | Auspex Pharmaceuticals, Inc. | Deuterated chlorokynurenines for the treatment of neuropsychiatric disorders |
| EP3427729A1 (en) * | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
| JP7431163B2 (ja) | 2018-02-09 | 2024-02-14 | ヴィスタゲン セラピューティクス、インコーポレイテッド | ４－クロロキヌレニンおよび中間体の合成 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1179866B (it) * | 1984-12-12 | 1987-09-16 | Rotta Research Lab | Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono |
| IT1206078B (it) * | 1987-06-03 | 1989-04-14 | Polifarma Spa | Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico |
| IT1237472B (it) * | 1989-10-04 | 1993-06-07 | Polifarma Spa | Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico. |
| DE19502075A1 (de) * | 1995-01-24 | 1996-07-25 | Grohe Armaturen Friedrich | Auslaufarmatur mit Befestigungseinrichtung |
-
1992
- 1992-02-24 DE DE69201141T patent/DE69201141T2/de not_active Expired - Lifetime
- 1992-02-24 DE DE69226447T patent/DE69226447T2/de not_active Expired - Lifetime
- 1992-02-24 DK DK92103066.4T patent/DK0501378T3/da active
- 1992-02-24 ES ES92103066T patent/ES2069921T3/es not_active Expired - Lifetime
- 1992-02-24 ES ES94110261T patent/ES2122098T3/es not_active Expired - Lifetime
- 1992-02-24 DK DK94110261T patent/DK0624569T3/da active
- 1992-02-24 EP EP92103066A patent/EP0501378B1/en not_active Expired - Lifetime
- 1992-02-24 AT AT94110261T patent/ATE168989T1/de active
- 1992-02-24 EP EP94110261A patent/EP0624569B1/en not_active Expired - Lifetime
- 1992-02-24 AU AU11144/92A patent/AU643365B2/en not_active Expired
- 1992-02-24 AT AT92103066T patent/ATE116969T1/de active
- 1992-02-25 NZ NZ24171892A patent/NZ241718A/en not_active IP Right Cessation
- 1992-02-25 CA CA002061836A patent/CA2061836C/en not_active Expired - Lifetime
- 1992-02-27 KR KR1019920003053A patent/KR100237264B1/ko not_active IP Right Cessation
- 1992-02-27 HU HU9200658A patent/HU213214B/hu unknown
- 1992-02-27 NO NO920784A patent/NO178727C/no not_active IP Right Cessation
- 1992-02-27 IE IE920631A patent/IE65728B1/en not_active IP Right Cessation
- 1992-02-27 IE IE950570A patent/IE80774B1/en not_active IP Right Cessation
- 1992-02-27 FI FI920880A patent/FI920880A/fi not_active Application Discontinuation
- 1992-02-27 JP JP07568392A patent/JP3168566B2/ja not_active Expired - Lifetime
-
1993
- 1993-08-31 AU AU44975/93A patent/AU656278B2/en not_active Expired
-
1995
- 1995-02-22 GR GR950400350T patent/GR3015130T3/el unknown
-
1999
- 1999-05-20 KR KR1019990018238A patent/KR100261933B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107401T1 (el) | Παραγωγα βενζοθειαζολιου πα την θεραπευτικη αντιμετωπιση της νοσου alzheimer και της νοσου parkinson | |
| EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
| ES2052717T3 (es) | Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson. | |
| DK0624569T3 (da) | MMDA-antagonister | |
| ES2051834T3 (es) | El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad. | |
| CY1119257T1 (el) | Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda) | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
| NO891390D0 (no) | Fremgangsmaate for fremstilling av bicykliske aminforbindelser. | |
| DK0626367T3 (da) | (7S)-7- (2R)-2-(3-chlorphenyl)-2-hydroxyethylamino -5,6,7,8-tetrahydronapthalen-2-yloxyeddikesyre og farmaceutisk acceptable salte deraf med beta3-adrenerg agonistvirkning, farmaceutiske præparater og laboratoriereagenser som indeholder den. | |
| DK526087A (da) | Antikonvulsive aminosyrederivater | |
| PT732332E (pt) | Benzotienilpiperazinas substituidas sua utilizacao como medicamentos e processos para a sua preparacao | |
| IT1307786B1 (it) | Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali. | |
| PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central | |
| DK1142575T3 (da) | Lægemidler til tör hud | |
| RU94017664A (ru) | Соединения, используемые в качестве антагонистов 5-нт-рецепторов, способ получения, фармацевтическая композиция | |
| TH20641A (th) | 6-[ไทรแอโซลิล[3-(ไทรฟลูออโรเมธิล)เฟนิล]เมธิล]-2-ควิโนลิโนนและ-ควิโนลีนไธโอน |